首页>
外国专利>
use of nalmefene or naltrexone for the manufacture of a medicinal product for the treatment of autoimmune diseases
use of nalmefene or naltrexone for the manufacture of a medicinal product for the treatment of autoimmune diseases
展开▼
机译:纳美芬或纳曲酮在生产用于治疗自身免疫性疾病的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method of treating a human or animal patient suffering from an autoimmune disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene (6-methylene-6-desoxy-N-cyclopropyl-methyl-14--hydroxydihydronormorphine) or naltrexone (N-cyclopropylmethyl--14-hydroxy-dihydromorphinone) may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
展开▼